The gross proceeds to the Company from the offering are expected to be approximately $5.0 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. The ...
Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced the pricing of ...
Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its fourth quarter and full year 2025 financial ...
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics, Inc. aims to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with ...
"The Phase 3 trial in adults with SR-aGvHD will position Ryoncil ® as the earliest treatment regimen for severe disease after steroid resistance." Mesoblast (the Company) is a world leader in ...
Samkari, MD (Massachusetts General Hospital, Harvard Medical School), who will join company management. During the event, the management team will review the target, mechanistic rationale, and ...
According to publicly available company disclosures, Java Burn Drops lists chlorogenic acid, Camellia sinensis, chromium, L-carnitine, L-theanine, and a vitamin complex among its primary ingredients.
Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease ...
Fourth Quarter 2025 Financial Results (Fourth Quarter 2025 compared to Fourth Quarter 2024) Revenue increased 12% to $269.1 million primarily driven by growth at existing centers and new center ...
Biogen Inc. (Nasdaq: BIIB) today announced that the Board of Directors has elected Dr. Maria C. Freire as Chair of the Board of Directors, effective immediately following the Company’s 2026 Annual ...
About RxSight, Inc. RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight ® Light Adjustable ...
Dr. Czech is a world-renowned biochemist and professor emeritus at UMass Chan, best known for foundational discoveries in insulin signaling, adipocyte biology, and metabolic regulation. His decades of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results